Panacea Life Sciences Holdings Inc (PLSH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 2,385 | 1,627 | 2,060 | 9,018 | 346 |
| Cost of Goods | 1,263 | 1,231 | 1,519 | 7,020 | 2,046 |
| Gross Profit | 1,122 | 397 | 541 | 1,998 | -1,701 |
| Operating Expenses | 6,931 | 6,279 | 6,997 | 7,276 | 9,018 |
| Operating Income | -5,546 | -5,652 | -5,937 | -5,258 | -10,673 |
| Interest Expense | 1,556 | 2,048 | 1,105 | 1,512 | 479 |
| Other Income | -913 | -1,442 | 2,260 | 1,538 | 1,133 |
| Pre-tax Income | -8,015 | -9,143 | -4,782 | -5,232 | -10,019 |
| Net Income Continuous | -8,015 | -9,143 | -4,782 | -5,232 | -10,019 |
| Minority Interests | N/A | N/A | N/A | N/A | -538 |
| Net Income | $-8,015 | $-9,143 | $-4,782 | $-5,232 | $-9,481 |
| EPS Basic Total Ops | -0.48 | -0.62 | -0.28 | -0.31 | -8.68 |
| EPS Basic Continuous Ops | -0.48 | -0.62 | -0.28 | -0.31 | -8.28 |
| EPS Diluted Total Ops | -0.48 | -0.62 | -0.28 | -0.31 | -8.68 |
| EPS Diluted Continuous Ops | -0.48 | -0.62 | -0.28 | -0.31 | -8.28 |
| EPS Diluted Before Non-Recurring Items | -0.48 | -0.62 | -0.37 | N/A | -8.68 |
| EBITDA(a) | $-3,795 | $-2,854 | $-4,083 | $-3,566 | $-9,069 |